nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—NEK11—adrenal gland—endogenous depression	0.03	0.051	CbGeAlD
Dabrafenib—NEK11—thyroid gland—endogenous depression	0.029	0.0493	CbGeAlD
Dabrafenib—NEK11—cerebellum—endogenous depression	0.0229	0.039	CbGeAlD
Dabrafenib—LIMK1—adrenal gland—endogenous depression	0.0215	0.0365	CbGeAlD
Dabrafenib—LIMK1—midbrain—endogenous depression	0.0212	0.0361	CbGeAlD
Dabrafenib—LIMK1—thyroid gland—endogenous depression	0.0207	0.0353	CbGeAlD
Dabrafenib—NEK11—brain—endogenous depression	0.0186	0.0317	CbGeAlD
Dabrafenib—SIK1—forebrain—endogenous depression	0.0166	0.0282	CbGeAlD
Dabrafenib—SLCO1B1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.0166	0.0403	CbGpPWpGaD
Dabrafenib—LIMK1—cerebellum—endogenous depression	0.0164	0.0279	CbGeAlD
Dabrafenib—LIMK1—RAC1 signaling pathway—WASF2—endogenous depression	0.0155	0.0377	CbGpPWpGaD
Dabrafenib—BRAF—pituitary gland—endogenous depression	0.0149	0.0253	CbGeAlD
Dabrafenib—LIMK1—RAC1 signaling pathway—WASF1—endogenous depression	0.0149	0.0361	CbGpPWpGaD
Dabrafenib—LIMK1—Regulation of actin dynamics for phagocytic cup formation—WASF2—endogenous depression	0.0148	0.0361	CbGpPWpGaD
Dabrafenib—LIMK1—Regulation of actin dynamics for phagocytic cup formation—WASF1—endogenous depression	0.0142	0.0346	CbGpPWpGaD
Dabrafenib—RAF1—brainstem—endogenous depression	0.0137	0.0233	CbGeAlD
Dabrafenib—LIMK1—brain—endogenous depression	0.0133	0.0227	CbGeAlD
Dabrafenib—BRAF—adrenal gland—endogenous depression	0.0133	0.0226	CbGeAlD
Dabrafenib—RAF1—forebrain—endogenous depression	0.0132	0.0225	CbGeAlD
Dabrafenib—BRAF—midbrain—endogenous depression	0.0131	0.0223	CbGeAlD
Dabrafenib—BRAF—thyroid gland—endogenous depression	0.0128	0.0218	CbGeAlD
Dabrafenib—SLCO1B3—pituitary gland—endogenous depression	0.0128	0.0218	CbGeAlD
Dabrafenib—SIK1—pituitary gland—endogenous depression	0.0124	0.0211	CbGeAlD
Dabrafenib—RAF1—adrenal cortex—endogenous depression	0.0123	0.0208	CbGeAlD
Dabrafenib—SIK1—Circadian rythm related genes—TPH1—endogenous depression	0.0113	0.0275	CbGpPWpGaD
Dabrafenib—LIMK1—Fcgamma receptor (FCGR) dependent phagocytosis—WASF2—endogenous depression	0.0112	0.0272	CbGpPWpGaD
Dabrafenib—RAF1—cardiovascular system—endogenous depression	0.0112	0.019	CbGeAlD
Dabrafenib—BRAF—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—endogenous depression	0.0112	0.0271	CbGpPWpGaD
Dabrafenib—SIK1—adrenal gland—endogenous depression	0.0111	0.0189	CbGeAlD
Dabrafenib—LIMK1—Fcgamma receptor (FCGR) dependent phagocytosis—WASF1—endogenous depression	0.0107	0.0261	CbGpPWpGaD
Dabrafenib—SIK1—thyroid gland—endogenous depression	0.0107	0.0182	CbGeAlD
Dabrafenib—BRAF—cerebellum—endogenous depression	0.0101	0.0172	CbGeAlD
Dabrafenib—SLCO1B3—endocrine gland—endogenous depression	0.00993	0.0169	CbGeAlD
Dabrafenib—RAF1—pituitary gland—endogenous depression	0.00991	0.0168	CbGeAlD
Dabrafenib—SIK1—endocrine gland—endogenous depression	0.00964	0.0164	CbGeAlD
Dabrafenib—SIK1—nervous system—endogenous depression	0.00902	0.0153	CbGeAlD
Dabrafenib—RAF1—adrenal gland—endogenous depression	0.00885	0.015	CbGeAlD
Dabrafenib—RAF1—midbrain—endogenous depression	0.00874	0.0148	CbGeAlD
Dabrafenib—SIK1—central nervous system—endogenous depression	0.00869	0.0148	CbGeAlD
Dabrafenib—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—endogenous depression	0.00865	0.021	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—TPH2—endogenous depression	0.00859	0.0209	CbGpPWpGaD
Dabrafenib—RAF1—thyroid gland—endogenous depression	0.00854	0.0145	CbGeAlD
Dabrafenib—SIK1—cerebellum—endogenous depression	0.00849	0.0144	CbGeAlD
Dabrafenib—RAF1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2C—endogenous depression	0.00846	0.0206	CbGpPWpGaD
Dabrafenib—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.0083	0.0202	CbGpPWpGaD
Dabrafenib—BRAF—brain—endogenous depression	0.00824	0.014	CbGeAlD
Dabrafenib—BRAF—Serotonin Receptor 4/6/7 and NR3C Signaling—NR3C1—endogenous depression	0.00817	0.0199	CbGpPWpGaD
Dabrafenib—RAF1—endocrine gland—endogenous depression	0.00767	0.013	CbGeAlD
Dabrafenib—SIK1—Circadian rythm related genes—CRH—endogenous depression	0.00739	0.018	CbGpPWpGaD
Dabrafenib—CYP2C8—CYP2E1 reactions—CYP2D6—endogenous depression	0.00739	0.0179	CbGpPWpGaD
Dabrafenib—RAF1—nervous system—endogenous depression	0.00718	0.0122	CbGeAlD
Dabrafenib—RAF1—central nervous system—endogenous depression	0.00691	0.0118	CbGeAlD
Dabrafenib—SIK1—brain—endogenous depression	0.0069	0.0117	CbGeAlD
Dabrafenib—LIMK1—Regulation of Actin Cytoskeleton—WASF2—endogenous depression	0.00688	0.0167	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—SLC6A4—endogenous depression	0.00687	0.0167	CbGpPWpGaD
Dabrafenib—RAF1—cerebellum—endogenous depression	0.00676	0.0115	CbGeAlD
Dabrafenib—LIMK1—Regulation of Actin Cytoskeleton—WASF1—endogenous depression	0.0066	0.016	CbGpPWpGaD
Dabrafenib—ABCG2—Fluoropyrimidine Activity—DPYD—endogenous depression	0.00608	0.0148	CbGpPWpGaD
Dabrafenib—SIK1—Circadian rythm related genes—HTR7—endogenous depression	0.00602	0.0146	CbGpPWpGaD
Dabrafenib—SLCO1B1—endocrine gland—endogenous depression	0.00574	0.00976	CbGeAlD
Dabrafenib—RAF1—brain—endogenous depression	0.00549	0.00933	CbGeAlD
Dabrafenib—SLC22A6—brain—endogenous depression	0.00533	0.00906	CbGeAlD
Dabrafenib—RAF1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—endogenous depression	0.00519	0.0126	CbGpPWpGaD
Dabrafenib—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00512	0.0124	CbGpPWpGaD
Dabrafenib—ABCG2—adrenal cortex—endogenous depression	0.00507	0.00862	CbGeAlD
Dabrafenib—RAF1—FSH signaling pathway—BDNF—endogenous depression	0.00483	0.0117	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—ANK3—endogenous depression	0.00468	0.0114	CbGpPWpGaD
Dabrafenib—CYP2C8—Xenobiotics—CYP2D6—endogenous depression	0.00458	0.0111	CbGpPWpGaD
Dabrafenib—BRAF—ErbB1 downstream signaling—WASF2—endogenous depression	0.00455	0.0111	CbGpPWpGaD
Dabrafenib—CYP2C8—Tamoxifen metabolism—CYP2D6—endogenous depression	0.0044	0.0107	CbGpPWpGaD
Dabrafenib—CYP2C8—pituitary gland—endogenous depression	0.00421	0.00716	CbGeAlD
Dabrafenib—SLC22A8—nervous system—endogenous depression	0.00418	0.0071	CbGeAlD
Dabrafenib—ABCG2—pituitary gland—endogenous depression	0.0041	0.00696	CbGeAlD
Dabrafenib—SLC22A8—central nervous system—endogenous depression	0.00402	0.00683	CbGeAlD
Dabrafenib—RAF1—NCAM signaling for neurite out-growth—CACNB2—endogenous depression	0.00398	0.00966	CbGpPWpGaD
Dabrafenib—BRAF—PDGFR-beta signaling pathway—WASF2—endogenous depression	0.00396	0.00962	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—CRH—endogenous depression	0.00388	0.00943	CbGpPWpGaD
Dabrafenib—ABCG2—adrenal gland—endogenous depression	0.00366	0.00622	CbGeAlD
Dabrafenib—ABCG2—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.00364	0.00885	CbGpPWpGaD
Dabrafenib—RAF1—NCAM signaling for neurite out-growth—CACNA1C—endogenous depression	0.00364	0.00883	CbGpPWpGaD
Dabrafenib—ABCG2—midbrain—endogenous depression	0.00361	0.00614	CbGeAlD
Dabrafenib—ABCG2—thyroid gland—endogenous depression	0.00353	0.006	CbGeAlD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—WASF2—endogenous depression	0.00344	0.00836	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—ANK3—endogenous depression	0.00334	0.00811	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—WASF1—endogenous depression	0.0033	0.00802	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—CACNB2—endogenous depression	0.0033	0.00801	CbGpPWpGaD
Dabrafenib—CYP2C8—endocrine gland—endogenous depression	0.00326	0.00555	CbGeAlD
Dabrafenib—SLC22A8—brain—endogenous depression	0.00319	0.00542	CbGeAlD
Dabrafenib—RAF1—ErbB1 downstream signaling—WASF2—endogenous depression	0.00315	0.00766	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—WASF2—endogenous depression	0.0031	0.00754	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—CACNA1C—endogenous depression	0.00301	0.00732	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—WASF1—endogenous depression	0.00298	0.00723	CbGpPWpGaD
Dabrafenib—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—endogenous depression	0.00294	0.00714	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—WASF2—endogenous depression	0.00293	0.00712	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—WASF1—endogenous depression	0.00281	0.00682	CbGpPWpGaD
Dabrafenib—ABCG2—cerebellum—endogenous depression	0.0028	0.00475	CbGeAlD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—WASF2—endogenous depression	0.00274	0.00666	CbGpPWpGaD
Dabrafenib—ABCB1—forebrain—endogenous depression	0.0027	0.00459	CbGeAlD
Dabrafenib—RAF1—Corticotropin-releasing hormone—CRH—endogenous depression	0.00268	0.00652	CbGpPWpGaD
Dabrafenib—RAF1—SHP2 signaling—BDNF—endogenous depression	0.00262	0.00637	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—GATA3—endogenous depression	0.00254	0.00617	CbGpPWpGaD
Dabrafenib—ABCB1—adrenal cortex—endogenous depression	0.0025	0.00425	CbGeAlD
Dabrafenib—CYP3A4—Xenobiotics—CYP2D6—endogenous depression	0.00246	0.00597	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.00242	0.00589	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—WASF2—endogenous depression	0.00238	0.00579	CbGpPWpGaD
Dabrafenib—CYP3A4—Tamoxifen metabolism—CYP2D6—endogenous depression	0.00236	0.00574	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—CACNB2—endogenous depression	0.00235	0.00571	CbGpPWpGaD
Dabrafenib—CYP2C8—brain—endogenous depression	0.00234	0.00397	CbGeAlD
Dabrafenib—LIMK1—Innate Immune System—WASF2—endogenous depression	0.00233	0.00566	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—WASF1—endogenous depression	0.00228	0.00555	CbGpPWpGaD
Dabrafenib—ABCB1—cardiovascular system—endogenous depression	0.00228	0.00388	CbGeAlD
Dabrafenib—ABCG2—brain—endogenous depression	0.00227	0.00386	CbGeAlD
Dabrafenib—LIMK1—Innate Immune System—WASF1—endogenous depression	0.00223	0.00543	CbGpPWpGaD
Dabrafenib—CYP3A4—endocrine gland—endogenous depression	0.00221	0.00376	CbGeAlD
Dabrafenib—LIMK1—Developmental Biology—CACNA1C—endogenous depression	0.00215	0.00523	CbGpPWpGaD
Dabrafenib—CYP3A4—Tryptophan metabolism—TPH1—endogenous depression	0.00208	0.00506	CbGpPWpGaD
Dabrafenib—CYP3A4—nervous system—endogenous depression	0.00207	0.00352	CbGeAlD
Dabrafenib—CYP3A4—Estrogen metabolism—COMT—endogenous depression	0.00203	0.00492	CbGpPWpGaD
Dabrafenib—ABCB1—pituitary gland—endogenous depression	0.00202	0.00343	CbGeAlD
Dabrafenib—CYP3A4—central nervous system—endogenous depression	0.00199	0.00339	CbGeAlD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.00197	0.00479	CbGpPWpGaD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.0019	0.00462	CbGpPWpGaD
Dabrafenib—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00188	0.00456	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—CACNB2—endogenous depression	0.00186	0.00451	CbGpPWpGaD
Dabrafenib—ABCB1—adrenal gland—endogenous depression	0.0018	0.00307	CbGeAlD
Dabrafenib—ABCB1—midbrain—endogenous depression	0.00178	0.00303	CbGeAlD
Dabrafenib—BRAF—Corticotropin-releasing hormone—POMC—endogenous depression	0.00177	0.00429	CbGpPWpGaD
Dabrafenib—ABCB1—thyroid gland—endogenous depression	0.00174	0.00296	CbGeAlD
Dabrafenib—RAF1—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.00168	0.00407	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—ANK3—endogenous depression	0.00162	0.00393	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—BDNF—endogenous depression	0.00162	0.00393	CbGpPWpGaD
Dabrafenib—ABCB1—endocrine gland—endogenous depression	0.00157	0.00266	CbGeAlD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.00154	0.00375	CbGpPWpGaD
Dabrafenib—BRAF—Transmission across Chemical Synapses—COMT—endogenous depression	0.00147	0.00357	CbGpPWpGaD
Dabrafenib—ABCB1—nervous system—endogenous depression	0.00146	0.00249	CbGeAlD
Dabrafenib—BRAF—Transmission across Chemical Synapses—MAOA—endogenous depression	0.00146	0.00354	CbGpPWpGaD
Dabrafenib—ABCB1—central nervous system—endogenous depression	0.00141	0.0024	CbGeAlD
Dabrafenib—ABCB1—cerebellum—endogenous depression	0.00138	0.00234	CbGeAlD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.00136	0.00331	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—WASF2—endogenous depression	0.00136	0.0033	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—WASF1—endogenous depression	0.0013	0.00316	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—CACNB2—endogenous depression	0.00128	0.00312	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—BDNF—endogenous depression	0.00127	0.00308	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.00127	0.00307	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—POMC—endogenous depression	0.00122	0.00297	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.00116	0.00282	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—ANK3—endogenous depression	0.00115	0.00281	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—CACNB2—endogenous depression	0.00114	0.00277	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—COMT—endogenous depression	0.00113	0.00273	CbGpPWpGaD
Dabrafenib—ABCB1—brain—endogenous depression	0.00112	0.0019	CbGeAlD
Dabrafenib—RAF1—MAPK Signaling Pathway—BDNF—endogenous depression	0.00112	0.00272	CbGpPWpGaD
Dabrafenib—BRAF—Neuronal System—MAOA—endogenous depression	0.00112	0.00271	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—CACNA1C—endogenous depression	0.00104	0.00253	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.00102	0.00248	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—COMT—endogenous depression	0.00102	0.00247	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.00101	0.00245	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—MAOA—endogenous depression	0.00101	0.00245	CbGpPWpGaD
Dabrafenib—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.00101	0.00245	CbGpPWpGaD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000931	0.00226	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL10—endogenous depression	0.000921	0.00224	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000827	0.00201	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—CYP2D6—endogenous depression	0.000819	0.00199	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CACNB2—endogenous depression	0.000814	0.00198	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—CYP2D6—endogenous depression	0.000807	0.00196	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—WASF2—endogenous depression	0.000806	0.00196	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—COMT—endogenous depression	0.000778	0.00189	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	0.000776	0.00189	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—MAOA—endogenous depression	0.000773	0.00188	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—WASF1—endogenous depression	0.000773	0.00188	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000755	0.00183	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CACNA1C—endogenous depression	0.000744	0.00181	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—GATA3—endogenous depression	0.000638	0.00155	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000623	0.00151	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—COMT—endogenous depression	0.00062	0.00151	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—MAOA—endogenous depression	0.000616	0.0015	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—COMT—endogenous depression	0.000612	0.00149	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—TPH1—endogenous depression	0.000599	0.00145	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.0005	0.00121	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.000476	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—ADM—endogenous depression	0.00047	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—WASF2—endogenous depression	0.000469	0.00114	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—TPH2—endogenous depression	0.000454	0.0011	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CACNB2—endogenous depression	0.000454	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—WASF1—endogenous depression	0.00045	0.00109	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—DPYD—endogenous depression	0.000446	0.00108	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—CYP2D6—endogenous depression	0.000439	0.00107	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—WASF2—endogenous depression	0.000439	0.00107	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—CYP2D6—endogenous depression	0.000433	0.00105	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—WASF1—endogenous depression	0.000421	0.00102	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CACNA1C—endogenous depression	0.000415	0.00101	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000405	0.000985	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—TPH1—endogenous depression	0.000402	0.000977	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ADM—endogenous depression	0.000401	0.000975	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—POMC—endogenous depression	0.000401	0.000975	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000399	0.000969	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—OXT—endogenous depression	0.000394	0.000957	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CRH—endogenous depression	0.000394	0.000957	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR1A—endogenous depression	0.000379	0.000921	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—TPH1—endogenous depression	0.000372	0.000905	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR2C—endogenous depression	0.000366	0.00089	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—CYP2D6—endogenous depression	0.000363	0.000881	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CRH—endogenous depression	0.000336	0.000817	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—OXT—endogenous depression	0.000336	0.000817	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—COMT—endogenous depression	0.000333	0.000809	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—MAOA—endogenous depression	0.000331	0.000804	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—COMT—endogenous depression	0.000328	0.000798	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR1A—endogenous depression	0.000324	0.000787	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR7—endogenous depression	0.000321	0.000779	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR2C—endogenous depression	0.000313	0.00076	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CACNB2—endogenous depression	0.000305	0.000741	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—TPH2—endogenous depression	0.000305	0.000741	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—WASF2—endogenous depression	0.000304	0.000738	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—DPYD—endogenous depression	0.0003	0.000729	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—WASF1—endogenous depression	0.000291	0.000707	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—TPH2—endogenous depression	0.000282	0.000686	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CACNB2—endogenous depression	0.000282	0.000686	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CACNA1C—endogenous depression	0.000279	0.000677	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—DPYD—endogenous depression	0.000278	0.000675	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ADM—endogenous depression	0.000278	0.000675	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—COMT—endogenous depression	0.000275	0.000668	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR7—endogenous depression	0.000274	0.000665	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MAOA—endogenous depression	0.000273	0.000663	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000268	0.000651	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CACNA1C—endogenous depression	0.000258	0.000627	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CYP2D6—endogenous depression	0.000244	0.000592	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CRH—endogenous depression	0.000233	0.000565	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—OXT—endogenous depression	0.000233	0.000565	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—TPH1—endogenous depression	0.000231	0.000562	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CYP2D6—endogenous depression	0.000226	0.000548	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—HTR2A—endogenous depression	0.000225	0.000546	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR1A—endogenous depression	0.000224	0.000544	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2C—endogenous depression	0.000216	0.000526	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—POMC—endogenous depression	0.000215	0.000523	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—TPH1—endogenous depression	0.000201	0.000489	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—HTR2A—endogenous depression	0.000192	0.000466	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR7—endogenous depression	0.000189	0.00046	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—COMT—endogenous depression	0.000185	0.000449	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MAOA—endogenous depression	0.000183	0.000446	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—POMC—endogenous depression	0.000179	0.000436	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—POMC—endogenous depression	0.000178	0.000432	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—TPH2—endogenous depression	0.000175	0.000426	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CACNB2—endogenous depression	0.000175	0.000426	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—DPYD—endogenous depression	0.000172	0.000419	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—COMT—endogenous depression	0.000171	0.000415	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MAOA—endogenous depression	0.00017	0.000413	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CACNA1C—endogenous depression	0.00016	0.000389	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000154	0.000374	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—POMC—endogenous depression	0.000153	0.000372	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CACNB2—endogenous depression	0.000153	0.000371	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—TPH2—endogenous depression	0.000153	0.000371	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—DPYD—endogenous depression	0.00015	0.000365	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP2D6—endogenous depression	0.00014	0.00034	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CACNA1C—endogenous depression	0.00014	0.000339	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HTR2A—endogenous depression	0.000133	0.000322	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TPH1—endogenous depression	0.000124	0.000301	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP2D6—endogenous depression	0.000122	0.000296	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—endogenous depression	0.000119	0.00029	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—endogenous depression	0.000111	0.000269	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—COMT—endogenous depression	0.000106	0.000258	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—endogenous depression	0.000106	0.000257	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MAOA—endogenous depression	0.000105	0.000256	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TPH2—endogenous depression	9.4e-05	0.000228	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CACNB2—endogenous depression	9.4e-05	0.000228	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—DPYD—endogenous depression	9.25e-05	0.000225	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—COMT—endogenous depression	9.24e-05	0.000225	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MAOA—endogenous depression	9.18e-05	0.000223	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CACNA1C—endogenous depression	8.6e-05	0.000209	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP2D6—endogenous depression	7.52e-05	0.000183	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—endogenous depression	6.86e-05	0.000167	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—endogenous depression	5.98e-05	0.000145	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—COMT—endogenous depression	5.7e-05	0.000138	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MAOA—endogenous depression	5.66e-05	0.000137	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—endogenous depression	3.68e-05	8.95e-05	CbGpPWpGaD
